19.02.10 Low level mutation detection Flashcards
What is low level mutation detection?
- Detection of a variant population of DNA in a sample where the wild-type (wt) DNA greatly exceeds the variant DNA contribution
- Need to enrich sample to be able to detect it
List 3 applications when low level mutation detection may be required
1) Somatic mutations in tumour samples
2) Mutations in fetus using NIPD (cffDNA)
3) Heteroplasmic mutations in mtDNA genomes
Somatic mutations in tumour samples - why is low level detection required?
- Tumours are heterogeneous mix of WT and tumour DNA
- Detect mutation as early as possible from biopsy or blood containing cell free circulating tumour DNA (ctDNA)
- Assess residual disease after radiotherapy or surgery
- Disease staging/risk stratification for prognosis or personalised medicine
- Monitor therapy outcomes and cancer remission/relapse
NIPD mutation testing - why is low level detection required?
- cffDNA load is only 3-6% of the entire DNA population (i.e. rest is maternal DNA)
mtDNA testing - why is low level detection required?
- Mutant mtDNA can be only a small proportion of entire mtDNA
What is enrichment?
- Process that increases mutant allele concentration relative to WT alleles
- Needed to increase mutant level to one where accurate analysis is possible
- Protocol is different for known and unknown mutations
- Known mutations is much easier
Enrichment of known mutations - list techniques with moderate to high selectivity that preferentially destroy or block the WT allele
Most are allele-specific amplification (ASA) methodologies
1) Restriction endonuclease-mediated selective PCR (REMS-PCR)
2) Artificial introduction of a restriction site (AIRS) RFLP (restrcition fragment length polymorphism)
3) Peptide nucleic acid (PNA)-mediated PCR and locked nucleic acid (LNA)-mediated PCR
Restriction endonuclease-mediated selective PCR (REMS-PCR)
If pathogenic MUT alters the sequence of a restriction enzyme (RE), then can use that enzyme during PCR to digest WT amplicon (with intact restriction site) and will only amplify products fir the mutated allele
Artificial introduction of a restriction site (AIRS) RFLP (restrcition fragment length polymorphism)
If the MUT does not alter a RE site, AIRS uses a modified primer that selectively binds to WT allele and introduces a RE site into the WT PCR product during PCR. Then expose to RE, get digestion of WT product which produces smaller PCR products which can be seen on gel
Peptide nucleic acid (PNA)-mediated PCR and locked nucleic acid (LNA)-mediated PCR
Under certain PCR cycling conditions, the chemically modified PNA or LNA probes specific for the WT allele will bind to the WT DNA and block primer annealing
- Only get amplification of variant molecules
Enrichment of known mutations - list techniques with moderate to high selectivity that preferentially amplify the variant allele
- These use a primer with a sequence at the 3’ end that matches that of the mutant allele (but not the WT allele)
1) AS-PCR - allele-specific PCR (key technique)
2) ARMS (amp refractory mutation system)
3) Taqman or Scorpain real-time PCR
Enrichment of known mutations - list techniques with very high selectivity
1) RFLP-PCR based methods
2) RSM-PCR (restriction site mutation PCR)
3) Digital PCR (dPCR) - key technique
RFLP-PCR based methods
Uses thermostable restriction enzymes to differentiate between WT and mutant allele
RSM-PCR (restriction site mutation PCR)
Following PCR amplification of a sequence from genomic DNA, digestin with a RE generates an extra fragment (seen on gel) on either the WT allele OR the mutant allele
Digital PCR (dPCR)
- Within a sample individual nucleic acid molecules are partitioned into separate regions
- Each partition contains either a negative or positive reaction
- PCR is performed from a single template molecule
- Each well is analysed for the presence of PCR products of MUT or WT sequences using florescent probes
- Separation allows absolute quantification and a more reliable collection and sensitive measurement of nucleic acid amounts
- dPCR can be used for known and unknown mutations (for known mutations allele specific fluorescent probe detection using real-time PCR; unknown mutations use NGS to sequence products)